Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927742 · ClinicalTrials.gov registry record · NA
Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 368
- Enrollment target
NCT03927742 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 368 participants.
The verdict
NCT03927742, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 368 participants
- Enrollment target
Study Summary
Over 5 million new cases of skin cancer are diagnosed in the United States each year, more than all other cancers combined. Most of these cases are caused by excess exposure to ultraviolet radiation from the sun and artificial sources such as indoor tanning. Melanoma, approximately 87,000 of the annual skin cancer cases and one of the more deadly skin cancers, is on the rise. Previous research on these individuals suggests that while some change how much time they spend in the sun and adopt ways to protect themselves when in the sun, many do not. In our previous study, we found that 20% of melanoma survivors reported a sunburn in the past year and 10% intentionally went outside for a tan, both strong indicators of inappropriate sun exposure. Melanoma survivors are at high risk of second melanomas, making it critical that they spend less time in the sun or take actions to protect themselves when they are in the sun. No studies to date have investigated technology-based strategies in melanoma survivors to improve sun exposure and protection behaviors. This project will test whether a wearable device that tracks sun exposure and provides alerts regarding sun exposure and protection behaviors will increase sun protection behaviors in melanoma survivors. The use of wearable technology devices (e.g., Fitbit) has grown quickly over the last decade and studies using these devices to promote physical activity and weight loss have been promising. We will test the technology device versus a similar control device in 368 melanoma survivors and compare sun protection behaviors between the two groups. This project has the potential to identify a strategy that could significantly lower the number of melanoma survivors who go on to have a second melanoma diagnosis. Importantly, this easy to use technology could also be utilized by survivors' family members, who are also at higher risk for melanoma, and the general population as a means to reduce risk of all forms of skin cancer.
Interventions
- BEHAVIORAL Shade + app with messaging
- BEHAVIORAL Shape + app without messaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 368 participants |
| Start Date | 2020-06-09 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03927742
The ClinicalTrials.gov registry entry for NCT03927742 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Shade + app with messaging is the first listed.
NCT03927742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03927742 about?
NCT03927742 is a clinical study titled "Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors". Over 5 million new cases of skin cancer are diagnosed in the United States each year, more than all other cancers combined. Most of these cases are caused by excess exposure to ultraviolet radiation from the sun and artificial sources such as indoor tanning. Melanoma, approximately 87,000 of the ann...
What is the current status of trial NCT03927742?
This trial is currently completed. It is a NA study. The enrollment target is 368 participants. The study started on 2020-06-09. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03927742?
The interventions under investigation include: Shade + app with messaging (BEHAVIORAL), Shape + app without messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT03927742?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.